Britain city Sanofi covid-19 testing vaccine Britain city Sanofi

Novavax to explore combined influenza/Covid vaccine for use post-pandemic

Reading now: 106
www.livemint.com

Novavax Inc said on Tuesday it has set up a team of company veterans as it seeks U.S. regulatory approval for its seasonal influenza vaccine and to help develop a combined influenza/COVID-19 vaccine for use after the pandemic.The flu vaccine, NanoFlu, met the primary and secondary goals in late-stage comparison study with Sanofi's influenza vaccine Fluzone Quadrivalent earlier in the year.Novavax is among global drugmakers racing to develop a vaccine for COVID-19 and last month started a late-stage trial of its experimental vaccine, NVX-CoV2373, in the United Kingdom.NVX-CoV2373 is also being tested in two ongoing mid-stage trials that began in August.This story has been published from a wire agency feed without modifications to the.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA